Industry Focus

We’re re-airing one of our favorite episodes from last year -- we breakdown how scams works, the signs of a scam, and how you can protect yourself with Fool.com's resident detective, Matthew Cochrane. Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

Mortgage REITs can be attractive to income investors, with many sporting double-digit yields, but it’s important to know what you’re getting into before adding one to your portfolio. In this Industry Focus: Financialsepisode, Fool.com contributor Matt Frankel, CFP discusses the basics of this unique type of company. Plus, host Jason Moser gives his take on Docusign’s (NASDAQ: DOCU) latest earnings report, and the pair answer some listener emails. You’ll hear all this and more on this week’s episode! Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

2019 is the year of IPOs! We're digging through another prospectus from a soon-to-be-public tech company: Fiverr. The gig economy site is getting ready to go public, but should investors be excited? Stocks: UPWK Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

Since the oil price collapse of 2014, offshore drillers have languished, with several operators going bankrupt. However, stabilizing oil prices and declining breakeven levels for offshore oil has the industry poised for a turnaround. Motley Fool Contributor Jason Hall joins the show to discuss the current state of the industry and break down three major offshore operators. Stocks Mentioned: RIG, ESV, SDRL Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

Pinterest, Beyond Meat, and Uber might be grabbing all of the financial headlines, but a little-known medical device company called Shockwave Medical (NASDAQ:SWAV) recently went public and has been a massive winner for early investors. In this episode of Industry Focus: Healthcare, host Shannon Jones and fool.com contributors Brian Feroldi take a closer look at Shockwave Medical’s technology, market opportunity, and financial statements to discuss why Wall Street is so excited.   They also provide investors with an update on Novocure (NASDAQ:NVCR), which is another fast-growing medical device maker that recently secured an important regulatory win. Stocks mentioned: SWAV, NVCR Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

Over the last several years, nerdculture and pop culture have become one and the same, with Avengers movies and Game of Thrones dominating the conversation. As this interest has grown, businesses have moved to satisfy audience demand for products associated with pop culture. On today’s episode, Motley Fool Analyst Jim Gillies and Contributor Dan Kline join the show to break down two companies operating in the space: Gamestop and Funko. Stay tuned to the end to hear us discuss our favorite video games of all time! Stocks Mentioned: GME, FNKO, BKS Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

In this week’s episode of Industry Focus: Financials, Jason Moser sits down with analyst Auri Hughes in the latest installment of our Between Two Fools interview series. Then, Fool.com contributor Matt Frankel, CFP talks with Moser about why bank stocks have underperformed the market in the midst of the trade war, the most important things investors should look for in company 10k and 10q filings, and what to think about when rolling over a 401(k). All that, plus the latest stocks we’re watching on this week’s information-packed episode. Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

We've got our hands on Uber's first set of earnings results as a publicly traded company -- we talk about why losses widened and the comments from management that surprised us. Also, we hit a looming anti-trust issue for Apple. Stocks: AAPL, UBER, LYFT Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

A home is the largest purchase the average person makes in his or her lifetime. However, real estate transactions can be intimidating, and because most people only go through the process once or twice, it’s hard to develop the experience needed to “know what you don’t know.” To help bridge this knowledge gap, Motley Fool personal finance experts Dan Kline and Maurie Backman join the podcast to share their experience buying properties and their 5 best tips for buying a new home. Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter Thanks to Airbnb for supporting our show.  Go to airbnb.com/fool and start hosting and you’ll receive a $100 Amazon Gift Card if you generate $500 in booking value by July 31. Terms and conditions apply.

Here's why paying $2 million for Novartis' revolutionary gene therapy for SMA may not be as crazy as it sounds.  Also, why shares slumped after BioMarin reported its gene therapy may virtually eliminate bleeding in hemophilia A patients. Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

On this week’s episode of Industry Focus: Consumer Goods host Jason Moser and Fool.com contributor Asit Sharma take a look at the most recent quarters for The Home Depot and Lowe's and kick the tires on Canadian Tire. Plus Jason sits down with Motley Fool analyst Thomas King on a new installment of Between Two Fools! Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

Back in January, the FTC put out its antitrust case against Qualcomm and now we have Federal Judge Lucy Koh's decision. We explore the decision, what it means for Qualcomm and how it might radically change the business. Stocks: QCOM, AAPL

The real estate brokerage industry hasn’t changed much in decades, with high commissions and an opaque buying process. However, Redfin is changing the industry for the better, aiming to fulfill its mission to “Redefine real estate in the consumer’s favor.” With a powerful value proposition, capable management, and a huge addressable market, Redfin is an up-and-coming Rulebreaker that investors should be receiving investors’ attention. Motley Fool Analyst Tim Beyers and Industry Focus Host Nick Sciple, both Redfin shareholders, break down Redfin’s competitive advantages, opportunities, and risks on this week’s episode. Stocks Mentioned: RDFN, ZG Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

We highlight two biotech stocks making oral presentations that could move their share price next month. Plus, Emily Flippen discusses an SEC proposal that could change reporting requirements for early stage biotechs. Stocks: RGNX BPMC Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

Chinese coffee company Luckin has aggressive plans to add thousands of stores and it's willing to lose a lot of money to do that. That puts it in competition with Starbucks though there might be enough customers for both. In addition Target sold out of its exclusive Vineyard Vines collection and that may not be a good thing. Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

In the latest installment of our Between Two Fools interview series, host Jason Moser sits down with Prudential (NYSE: PRU) CFO Ken Tanji to talk about financial wellness and what the company is doing to try to improve the financial wellness of Americans. Plus, Fool.com contributor Matt Frankel, CFP talks about why Green Dot (NASDAQ: GDOT) plunged after its recent earnings report, and you’ll also hear what stocks are on our radar this week. All this and more on this week’s episode of Industry Focus: Financials. Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

We've got our hands on the first report for recently public Pinterest! We dive in and try and figure out why the stock sold off 10% after earnings, and check in on 2018 IPOs Upwork and Docusign to see how they're faring after their first year on the market. Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

If you took a hot shower this morning, there’s a good chance you got your hot water thanks to a product from A.O. Smith, America’s largest manufacturer of hot water heaters. Operating in an oligopoly market with growing demand as more of the world enters the middle class, A.O. Smith is up 9X over the last 10 years and counts itself among elite company as a dividend aristocrat.  With shares down today on a recent short report from J Capital Research, Motley Fool Analyst John Rotonti joins the show to break down the investment opportunities and risks surrounding A.O. Smith today. Stocks Mentioned: AOS Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter $50 off your first job post. Linkedin.com/fool  

It's a battle of the big bio's on this episode of Industry Focus Healthcare. Is Gilead Sciences finally overcoming its hep C headwind? Is Amgen beating back biosimilars? We dig into the details as we discuss which of these biopharma behemoths delivered better first quarter results. Stocks: GILD, AMGN Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter

You've undoubtedly been exposed to the multi-level marketing industry -- Facebook posts from people you went to high school with, phone calls asking you to come to Tupperware parties. Millions of Americans participate in the space, whether they call it "direct selling" "network marketing" or something else entirely. On this show, we explain why we won't invest in the industry, and how the average distributor tends to make out. Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter $50 off your first job post. Linkedin.com/fool